TrialEuropean journal of nuclear medicine and molecular imaging2013

Response assessment of bevacizumab in patients with recurrent malignant glioma using [18F]Fluoroethyl-L-tyrosine PET in comparison to MRI.

Norbert Galldiks et al.PubMed ↗Publisher ↗

No numbers read from the abstract.